Evaluating the safety and efficacy of axitinib in the treatment of advanced renal cell carcinoma

Overview of attention for article published in Cancer Management and Research, February 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)

Mentioned by

news: 1 news outlet

Citations

dimensions_citation: 46 Dimensions

Readers on

mendeley: 64 Mendeley

Summary News Dimensions citations

So far, Dimensions has found 46 publications that cite this research output.

46

The most recent citing publications are shown below. View all 46 publications that cite this research output on Dimensions.

Retroperitoneal laparoscopic radical nephrectomy in the treatment of renal cancer: a 5-year single-center experience in resource-scare setting

Article in Italian Journal of Medicine (July 2024)

Systemic hypertension with VEGFR inhibitor (axitinib) therapy in cancer patients: A meta-analysis and systematic review of randomized controlled trials

Article in IJC Heart & Vasculature (May 2024)

Potentials and future perspectives of multi-target drugs in cancer treatment: the next generation anti-cancer agents

Article in Cell Communication and Signaling (April 2024)